Finance

Lists
QNRX:NASDAQ
Quoin Pharmaceuticals Ltd - ADR
$4.10
-1.20%
(-0.050) 1D
Oct 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for QNRX...
Open
$4.11
High
$4.29
Low
$3.91
Mkt. cap
19.70M
Avg. vol.
82.54K
Volume
159.06K
52-wk high
$23.50
52-wk low
$3.25
EPS
-$423.73
Beta
1.56
Shares outstanding
4.80M
No. of employees
5
Open
$4.11
High
$4.29
Low
$3.91
Mkt. cap
19.70M
Avg. vol.
82.54K
Volume
159.06K
52-wk high
$23.50
52-wk low
$3.25
EPS
-$423.73
Beta
1.56
Shares outstanding
4.80M
No. of employees
5
News stories
From web sources and news partners
About Quoin Pharmaceuticals Ltd - ADR
CEO-
Employees5
Founded1986
Headquarters-
SectorBiotechnology
Websitequoinpharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to QNRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for QNRX in the last 3 months.
Highest
Current $4.10
$35.00 (+753.66%)
Average
$22.25 (+442.68%)
Lowest
$14.00 (+241.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Initiated
$14.00
+241.5%
10/12/2026
Thomas Flaten
Lake Street
Buy
Initiated
$20.00
+387.8%
09/23/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$20.00
+387.8%
09/03/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$35.00
+753.7%
08/17/2026
Ashok Kumar
ThinkEquity
Buy
Initiated
$12.00
+192.7%
06/15/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$30.00
+631.7%
05/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.28M
3.10M
3.43M
3.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74M
1.42M
1.70M
1.85M
Operating expense
4.02M
4.52M
5.13M
5.47M
Total operating expenses
4.02M
4.52M
5.13M
5.47M
Operating income
-4.02M
-4.52M
-5.13M
-5.47M
Other non operating income
9.49K
364.00
-13.30K
1.58K
EBT including unusual items
-3.95M
-4.35M
-5.00M
-5.37M
EBT excluding unusual items
-3.95M
-4.35M
-5.00M
-5.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.95M
-4.35M
-5.00M
-5.37M
Net profit margin
-
-
-
-
Earnings per share
-6.70
-
-1.77
-1.90
Interest and investment income
62.27K
171.70K
146.78K
100.95K
Interest expense
-
-
-
-
Net interest expenses
62.27K
171.70K
146.78K
100.95K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.99M
-4.50M
-5.11M
-5.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps